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Abstract
Background: Metastatic carcinoma to the jaws and oral region are very rare, representing less than 1% of all oral 
tumors. Unfortunately, oral metastasis is usually manifestation of an advanced stage of primary cancer, and indi-
cates widespread disease and poor prognosis. 
Material and Methods: In this retrospective study, a total of 2039 patients with history of oral malignant tumor 
between 1980 and 2012 at Seoul National University Dental Hospital were evaluated. We analyzed the dental and 
medical records, and histopathological database of 2039 patients to assess the prevalence of oral metastasis of 
carcinoma in terms of sex and age, as well as, the most common origin of primary cancer, and prevalent site and 
histopathological type of metastatic carcinoma. 
Results: Among 2039 patients, 21 (1.03%) were finally diagnosed with metastatic carcinoma of the jaws and oral 
region. Among the 21 patients, only 11 had a working diagnosis as oral metastasis upon clinical evaluation before 
performing a biopsy. The mean age at the time of diagnosis with a metastatic carcinoma was 56.86, and there was 
a male preponderance. Metastatic carcinoma was more frequent in the jaws than in the soft tissue, especially in 
the mandible compared to the maxilla. The most frequent primary site was the lungs, followed by the liver and 
breasts. The predominant histopathological types were hepatocellular carcinoma and adenocarcinoma. Patient 
outcomes indicated a poor prognosis with the time from the appearance of the metastasis to death was only 12 
months.
Conclusions: According to these cases, oral metastases of carcinoma were exceedingly rare in Koreans. It can al-
low the clinicians take into account the possible presence of metastases and lead to early diagnosis.
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Introduction
Approximately 5% of all malignant tumors involve the 
oral region. Among them, metastatic tumors of the jaws 
and oral cavity are very rare, accounting for approxi-
mately 1% of all oral tumors (1,2). Hence, diagnosing 
a metastatic tumor in the jaws and oral cavity is very 
challenging for the both clinician and pathologist be-
cause of its rarity. Understanding metastasis is of great 
importance for the clinical management of cancer be-
cause min most cases, cancer-related mortality is asso-
ciated with disseminated metastatic lesions. In addition, 
in most cases, cancer patients with widespread and dis-
seminated tumors have significantly poorer prognoses 
than those with localized tumors (3). Unfortunately, 
several steps of carcinogenesis have already been ex-
plored (4,5), and the complex pathogenic mechanisms 
for spreading of primary tumor cells to the oral lesion 
are still uncertain (6). Although the metastatic site and 
the primary tumors might not always be directly con-
nected through the blood vessels, lymphatic vessels, or 
serosal surfaces (7), distinct and various sites might be 
involved in the metastatic process.
Metastatic carcinoma, the major type of metastatic can-
cer, can affect both the osseous and soft tissues. The 
most common site for bone metastasis in the head and 
neck region are the jaws, comprising more than 70% 
of all malignant metastatic tumors in the oral cavity 
(2). Many researchers have reported that metastasis to 
the oral soft tissue is rare compared to that to the jaws 
(2,8,9). In the soft tissue, the most frequently involved 
site is the attached gingiva, followed by the tongue. 
The tongue has a rich vascular supply and can easily be 
involved in cancer metastasis (10). According to Bern-
stein et al., cancer cells can also be transfer to the nasal 
cavity and paranasal sinuses (11).
Hashimoto et al. reported that metastatic carcinoma of 
the mandible was confirmed at autopsy in 16% of the pa-
tients with malignant tumors (12). Fifty percent of all oral 
metastases occurs from the primary carcinoma of breast, 
lung, and kidney. The remaining are from the prostate, 
thyroid, gastrointestinal tract, suprarenal, uterus, and 
bones (13). There are sex differences in the primary sites 
of metastases. In women, the most common sources of 
tumors metastatic to the oral region are primary cancers 
of the breasts and the reproductive organs, followed by 
the thyroid gland. In men, they are usually metastasized 
from the lungs and kidneys (14).
Despite the recent advances in diagnosis and treatment, 
prognosis still mostly depends on the stage of cancer at 
the diagnosis of the oral cavity lesion. If a metastasis can 
be quickly identify, while it is still localized with a lower 
stage or grade, the prognosis is better (15). However, oral 
metastases usually indicate widespread disease and poor 
prognosis. The time elapsed from the appearance of the 
metastasis to death is usually only a few months (2).
We aimed to evaluate the prevalence of metastatic car-
cinoma in the jaws and oral region in Korean patients 
indirectly, at a single institution, through direct analy-
sis of our data over a 32-year period. We analyzed its 
clinical characteristics and histopathological features in 
order to improve our knowledge of the nature of oral 
metastatic carcinoma, which can allow the clinicians 
and oral pathologists take into account the possible 
presence of metastases.
 
Material and Methods
All patients who were diagnosed with oral malignant 
tumors between January 1980 and December 2012 at 
the Department of Oral Pathology of Seoul National 
University Dental Hospital were enrolled in the present 
study. We retrospectively analyzed the histopathologi-
cal, dental, and medical records of 2039 patients with 
oral cancer to assess the prevalence of metastatic carci-
noma to the oral region. Cases satisfying the diagnostic 
criteria for oral metastatic carcinoma as recommended 
by Stern and Shepard (9) were included. All patients 
definitively diagnosed with metastatic carcinoma of the 
jaws and oral region based on complete information re-
garding the primary site, clinical presentation, radiolog-
ic findings, and histological features. Thus, we evaluat-
ed and analyzed the diagnosis of the primary lesion, the 
site of the primary tumor, time to metastasis, the choice 
of treatment (chemotherapy and/or radiation therapy), 
recurrence, and/or mortality, as well as the patient sex 
and age. The diagnosis for each patient was reconfirmed 
through microscopic examination of the cancer biopsy 
samples. The study was conducted in accordance with 
the ethical principles of the Declaration of Helsinki, and 
the protocol was approved by the institutional review 
board of Seoul National University Dental Hospital.
Results
- Prevalence
Over the last 32 years at our hospital, 2039 cases of ma-
lignant tumors in the jaws and oral region, including car-
cinomas (1981 cases), sarcomas (47 cases), melanomas 
(5 cases), and other unspecified malignant neoplasms (6 
cases) were diagnosed. Of the 2039 malignant cases, 21 
patients had metastatic carcinomas. The proportion of 
metastatic carcinomas accounted for 1.03% of all oral 
malignant tumors, and 1.06% of all oral carcinomas.
- Age and sex distributions
Most patients who were diagnosed with tumors meta-
static to the oral region (18/21 cases, 85.7%) were in their 
fourth to seventh decades. The mean age at the time of 
diagnosis with a metastatic carcinoma was 56.9 (range, 
31-83) years. The mean ages of the men and women 
were 60.2 and 52.8 years, respectively. The mean age 
of patients with jawbone metastases (56.2 years) was 
lower than that of patients with oral soft tissue metas-
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Case 
No. 
Age 
/sex 
Clinical 
signs 
 
Pathological dx. 
 
  Location 
 
Radiological 
features 
Primary 
site 
 
Tx. 
 
Meta.† 
(years) 
F/U‡ 
(months) 
1 45/F Pain, swelling 
Hepatocellular 
carcinoma Maxilla Mixed* Liver 
S, 
R, 
C 
3 25 
2 43/F Fistula, MOL 
Invasive ductal 
carcinoma Mandible Radiolucent Breasts 
S, 
R, 
C 
2 6 
3 48/F Pain Follicular carcinoma 
Parotid 
gland Radiolucent Thyroid 
R, 
C 1 7 
4 56/F Pain, swelling 
Hepatocellular 
carcinoma Mandible Radiolucent Liver 
S, 
R, 
C 
NA 12 
5 51/F Pain, bad smell 
Invasive ductal 
carcinoma Mandible Radiolucent Breasts 
S, 
R 2 10 
6 31/F Chin numbness 
Invasive ductal 
carcinoma Mandible Radiolucent Breasts 
S, 
R, 
C 
1 11 
7 64/F 
Pain, 
swelling, 
mobility 
Adenocarcinoma Oropharynx Radiolucent Lungs NA 3 NA 
8 74/F Pain, swelling 
Mucinous 
carcinoma Mandible Radiolucent Breasts 
S, 
R, 
C 
1 22 
9 52/M 
Pain, 
swelling, 
ulcer 
Adenocarcinoma Maxilla Radiolucent Rectum 
S, 
R, 
C 
1 10 
10 31/M Pain, swelling Choriocarcinoma Mandible Radiolucent Testes NA 2 NA 
11 83/M Mobility, ulcer 
Squamous cell 
carcinoma Maxilla Mixed* Lungs 
S, 
R, 
C 
4 Recurred 
12 46/M 
Swelling, 
mobility, 
exophytic 
lesion 
Adenocarcinoma Mandible Radiolucent Lungs 
S, 
R, 
C 
1 12 
13 54/M 
MOL, 
fistula, 
necrosis 
Follicular 
carcinoma Mandible Mixed* Thyroid NA 2 NA 
14 73/M Pain, swelling 
Hepatocellular 
carcinoma Mandible Radiolucent Liver NA 1 Recurred 
15 63/M Painless mass Adenocarcinoma Mandible Radiolucent Lungs S 2 10 
16 60/M Pain, swelling 
Hepatocellular 
carcinoma Mandible NS Liver 
S, 
R, 
C 
5 35 
17 70/M Painless mass Adenocarcinoma Tongue Mixed* Lungs 
S, 
R, 
C 
0.2 7 
18 63/M 
Bleeding, 
mobility, 
swelling 
Squamous cell 
carcinoma Mandible Radiolucent Lungs 
S, 
R, 
C 
1 8 
19 62/M Bleeding, swelling 
Renal cell 
carcinoma Mandible Radiolucent Kidneys NA 2 NA 
20 73/M 
Bleeding, 
swelling, 
pain 
Small cell 
carcinoma Mandible Radiolucent Lungs 
S, 
R, 
C 
3 NA 
21 52/M Pain Hepatocellular carcinoma Mandible NS Liver NA NA 2 
!
tases (59.0 years) and the mean age of patients with me-
tastases to the mandible (59.4 years) was slightly lower 
than that of patients with metastases to the maxilla (60.0 
years). Metastatic carcinomas were more prevalent in 
men (13/21 cases) than in women (8/21 cases), and 
the men to women ratio was 1.63:1. The patients with 
oral metastatic carcinomas were predominantly men, 
whereas, the patients with oral soft tissue metastases 
were predominantly women, with a men to women ratio 
of 1:2 (Tables 1,2).
Table 1. Clinical and radiological features of patients with metastatic carcinoma.
M, male; F, female; †Meta. (years), period for metastasis; ‡F/U, follow-up months before death; MOL, mouth opening limitation, C; 
chemotherapy, R; radiotherapy, S: surgery, Tx.; treatment, dx; diagnosis, NA; not available, NS; did not observe any pathological changes 
on radiographic examination. Mixed; mixed radiopaque-radiolucent lesions.
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Primary
site
Male/female
ratio
Mean age
(year)
Histological type
Number 
of cases
Total
(%)
Lungs 6:1 66.0
Adenocarcinoma
Squamous cell carcinoma
Small cell carcinoma
4
2
1
33.3
Liver 3:2 57.2 Hepatocellular carcinoma 5 23.7
Breasts 0:4 52.3
Invasive ductal carcinoma
Mucinous carcinoma
3
1
19.0
Thyroid 1:1 48.0 Follicular carcinoma 2 9.6
Rectum 1:0 52.0 Adenocarcinoma 1 4.8
Kidneys 1:0 62.0 Renal cell carcinoma 1 4.8
Testes 1:0 31.0 Choriocarcinoma 1 4.8
Total 13:8 56.9 21 100
- Primary site
Several primary malignancies have the potential to me-
tastasize to the oral region. In the present study, oral 
metastases most frequently originated from the lungs, 
liver, breasts, thyroid, and 1 case each from the kidneys, 
bladder, and the testes were observed. The site of origin 
differed between the sexes; for men, the most common 
site was the lungs, followed by the liver, thyroid, rectum, 
kidneys, and the testes. For women, it was the breasts, 
followed by the liver, lungs, and the thyroid (Tables 1,3).
- Metastatic carcinoma of the oral region
Primary tumors metastasized to the jaws (18/21 cases) 
in the oral region more frequently than they did to the 
oral soft tissues (3/21 cases). In the jaws, the mandible 
was the most common location (15/18 cases; 83.3%), 
followed by the maxilla (3/18 cases; 16.7%). In the 
soft tissues (3/21 cases), the tongue (1/3 cases), parotid 
gland (1/3 cases), and the oropharynx (1/3 cases) were 
the sites of metastases. In the mandible, the molar area 
was the most commonly affected region (8/15 cases, 
53.3%). There were 3 cases (20%) of non-localized 
spread throughout the entire mandible, followed by 1 
case (6.7%) each involving the ascending ramus, man-
dibular angle, mandibular condyle, and the retromolar 
trigone. In the maxilla, there were 2 cases involving the 
molar region (66.7%) and 1 case of spread throughout 
the entire maxilla (33.3%). There was 1 case (33.3%) 
involving the maxillary incisor region, which had not 
been previously reported (Table 2).
- Clinical presentation and radiological findings
The mean time elapsed from the appearance of oral 
symptoms to diagnosis was 3 months. The clinical pres-
entations of the oral metastatic lesions differed between 
various sites. More than half of the patients (57.1%) 
Table 2. Sites of metastases in the jaws and oral region.
Table 3. Histological type according to the primary site.
Location
Number of 
cases (%)
Male / female 
ratio
Jaws
Maxilla Anterior maxilla  1  (4.8) 0 : 1
Posterior maxilla  1  (4.8) 1 : 0
Not specified  1  (4.8) 1 : 0
Mandible
Posterior man-
dible
 12  (57.1) 7 : 5
Not specified   3  (14.3) 3 : 0
Soft 
tissues
Tongue
Parotid gland 
Oropharynx 
       1  (4.8)
       1  (4.8)
       1  (4.8)
1 : 0
0 : 1
0 : 1
Total 21 (100)  13 : 8
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complained of pain and swelling at the area of metasta-
sis. During oral examination, we noted common clinical 
symptoms with increased dental mobility in 4 (19.0%), 
bleeding in 3 (14.3%), limitation of mouth opening in 
2 (9.5%), and chin numbness in 1 (4.8%) out of the 21 
cases of oral metastasis (Table 1). Radiographic exami-
nation revealed a radiolucent lesion in 15 (71.4%), and 
mixed radiopaque-radiolucent lesions in 4 (19.0%) out 
of the 21 cases. However, in 2 out of 21 cases (9.5%), the 
radiographs did not show any pathological changes.
- Histopathological findings
The histopathological diagnoses of the oral metastatic 
carcinomas are listed in tables 1 and 3. Metastasis from 
the lungs was observed in 7 out of 21 cases, and the most 
common type was lung adenocarcinoma (4/7 cases), 
followed by squamous cell carcinoma (2/7 cases), and 
small cell carcinoma (1/7 cases). Metastasis from the 
liver was observed in 5 cases, and the histological type 
for all the cases was hepatocellular carcinoma, which is 
the most common type of liver cancer. The patients with 
metastases from the lungs had a mean age of 66 years 
and they were the oldest compared to the patients with 
metastases from other sites. Patients with metastases 
from the testes were the youngest with a mean age of 
31 years. The patients with primary follicular thyroid 
carcinoma, had a mean age of 48.0 years, which was 10 
years younger than the mean age of the 21 patients (56.9 
years) with oral metastases.
- Outcomes
The average time elapsed from the diagnosis of the 
primary tumor to the appearance of the jaw and oral 
region metastases, was 1.9 years (range, 1 month to 5 
years). Various treatment methods including lobectomy, 
hepatectomy, radical mastectomy with radiotherapy, 
and chemotherapy were used in the treatment of the pri-
mary cancers. However, the patient outcomes were very 
poor. The average time to death after the diagnosis of a 
metastatic carcinoma in the oral region was 12 (range, 
2-35) months. Ten patients (47.6%) died within 1 year of 
diagnosis, and the >2-year survival rate was 5%. Three 
patients (14.3%) showed metastases to organs and tis-
sues other than the oral region; 1 case involved breast 
cancer metastasis to the lungs and scapula, 1 case in-
volved primary lung cancer metastasized to the small 
intestine, and the last case involved primary lung cancer 
metastasized to the brain.
Discussion
Metastatic carcinoma to the jaws and oral region are 
rare and account for approximately 1% of all malig-
nant oral tumors (2). In the present study, among the 
2039 patients who were diagnosed with oral malignant 
tumors, only 21 patients had oral carcinomas metasta-
sized from other organs during the last 32 years. Most 
patients (85.7%) were in their fourth to seventh decades, 
with a mean age of 56.9 years. This finding is consist-
ent with the results of previous studies, which reported 
that oral metastatic tumors occur in patients aged 40-
70 years (16,17). The patients with jawbone metastases 
were younger than the patients who had oral soft tissue 
metastases, which is consistent with the findings of a 
previous study (18).
Whether oral metastasis has any predilection toward a 
particular sex is still controversial. The men to wom-
en ratio for the 21 patients with oral metastases, was 
1.63:1, whereas, oral soft tissue metastases showed a 
predominance for women. Hirshberg et al. reported that 
metastases to the jaws have a female predilection (18). 
Schwartz et al. also observed that jawbone metastases 
were more likely develop in women (19).  However, ac-
cording to an analysis of 390 cases, male predilection 
observed in both metastases to the oral mucosa and to 
the jaws (14). In other studies, there was an equal sex 
distribution for jawbone metastasis and a male predilec-
tion for oral soft tissue (6). In a Korean review, men had 
a higher rate of metastatic tumors, especially in the jaws 
(20). The patterns might differ with respect to factors 
such as race and patient population, or the nature of the 
research institutions. 
A literature review reported that the breasts, lungs, kid-
neys, and prostate were common sites of primary tu-
mors (13,14,16,17). The present study also showed that 
the common sources of metastatic carcinomas to the 
oral region were the lungs and the breasts. According 
to previous studies, the nature of the primary tumor and 
the site of metastasis within the oral region and jaws dif-
fered between sexes (16,17). In men, the primary tumors 
were the most commonly found in the lungs and kid-
neys, and the breast and thyroid tissues were the most 
common sources of metastasis in women. In the present 
retrospective analysis, the most common primary site 
in men was the lungs and in women it was the breast, 
which was consistent with the previous literatures. 
Although the high metastatic rate for the lung and breast 
is consistent with that of the Western literature, the in-
cidence rate for the liver cancer is inconsistent. Primary 
liver cancer is more common in Asia than in the West, 
and it has a poor prognosis with a low chance of surviv-
al past 1 year, whether the cancer is primary or second-
ary (21). We found a higher metastatic rate for the liver 
as a primary site in both sexes than that reported in the 
Western literature. McDaniel et al. (22) observed only 1 
out of the 32 cases of liver cancer metastasis to the oral 
region. According to the national statistics of Korea, the 
crude annual incidence rate among the Korean popu-
lation, the crude mortality rate for liver cancer during 
2010 in Korea was very high for both sexes (23). Based 
on these statistical characteristics of liver cancers in the 
Korean population, we could speculate on the possible 
reason behind the high number of oral metastases form 
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the liver. A recent literature review covering the 1983 to 
2004 period showed that liver cancer was the source of 
27% of total cases in the Korean population, which was 
even higher than our results (20).
Hepatocellular carcinoma (HCC), the most common 
primary tumor of the liver, was the most common his-
tologic type of metastatic carcinoma in this study. As 
a leading cause of death for both the Korean men and 
women, HCC has a mean survival of much less than 1 
year if left untreated (24). To our knowledge, the true in-
cidence of extrahepatic metastases to the jaws and oral 
region remains unknown. In addition, oral metastasis 
of hepatocellular carcinoma is uncommon with only 61 
publishing cases reported in the literature (25). HCC in 
advanced stages is very devastating and can easily form 
metastases to other organs, including the oral region 
(25). In addition, all HCC cases preferred skeletal bones 
to soft tissues as their metastatic target in the present 
study. It is probably due to the preference to the skeletal 
bones in some metastatic tumors. Of course, when we 
compared the relative prevalence of primary tumors, 
the incidence of the primary lesions in that particular 
population and specific ethnicity should be taken into 
account. 
The jaws, particularly the mandible, were the most fre-
quently involved sites, followed by the oral soft tissues. 
Consistent with previous findings in a systemic review 
(18), the present study also revealed that the mandible 
is the most common location for metastases, with the 
molar area being the most frequently involved site. The 
blood vessels in the posterior region of the mandible 
are well developed, which might help tumor cells to be-
come entrenched. However, the lack of hemopoiesis in 
the adult maxilla can explain the mandible being much 
more frequently affected than the maxilla (19). Early 
lodging of tumor cells occurs in the hemopoietic areas, 
and tumor cells appear in the most anterior part of the 
mandibular body or the soft tissues only in advanced 
stages of the disease (19). 
Although there are more published cases of metastases 
to the jawbone than to the oral soft tissues, metastatic 
tumors to the oral region might also manifest in the soft 
tissue (2). In the present analysis, 3 cases were con-
firmed to involve the oral soft tissue; a tongue, parotid 
gland, and oropharynx. Of the oral soft tissue tumors, 
the tongue is one of the most commonly affected sites. 
Because of richness of blood vessels, the tongue is eas-
ier for cancer cells to engraft along the veins (10,26). 
While the muscle is known to be resistant to metasta-
sis, the tongue is well vascularized and may have the 
potential to attract metastatic tumor cells (18). We had 
one case with parotid gland metastases. The major 
salivary glands reported as relatively common sites for 
oral metastasis. Among them, parotid gland is the most 
common salivary gland involved in the metastatic proc-
ess, followed with a much lower incidence in the sub-
mandibular gland (27). According to a literature review 
of 232 tumors that occurred in the parotid gland, 101 
patients had metastatic carcinoma (16). The difference 
between the two salivary glands can be explained with 
the absence of lymph nodes in the submandibular gland 
and the rich lymphatic plexus found within the parotid 
gland.
In the present study, pain and swelling in the oral region 
were some of the primary clinical symptoms of the pa-
tients. Numerous factors produced by the cancer cells, 
inflammatory cells, and various kinds of cells derived 
from bone marrow make it difficult to control the pain 
(28). In one of the cases that showed metastases to the 
mandible, which originated from the breast, numbness 
developed. Numb chin syndrome appears when meta-
static tumors are located in the mandible, especially 
when they invade the mandibular nerve, causing symp-
toms of numbness and intermittent pain, anesthesia, 
and hypoesthesia (29). As the metastasis progresses, 
the patient may feel a sense of severe discomfort in the 
soft tissues inside the mouth. If these symptoms are ob-
served, we have to consider a metastatic tumor in the 
differential diagnosis.
Metastatic carcinoma to the oral regions is one of the 
most devastating diseases, causing significant disfig-
urement of the patient with severe morbidity and mor-
tality (1,2). In case of metastasis to the oral cavity, the 
mean survival time was 7 months (13), which is relative-
ly shorter than that for metastasis to other parts of the 
body. Clinically, the primary origins are often already 
known to be in an advanced stage when the clinician 
diagnoses metastatic carcinoma. In the present study, 
all patients showed that advanced oral cancer with IVC 
TNM stage. According to several extensive reviews, 
oral metastasis usually indicates widespread metastases 
from the primary site (2,6,14). The treatments are also 
primarily dependent on the site of origin and the degree 
of metastatic spread (6). If the patient were in advanced 
malignant disease, a palliative regimen would be neces-
sary to improve the quality of life. When the patient is 
under the widespread or recurrent metastatic disease, 
the secondary lesion to the jaws and oral region should 
be managed conservatively to alleviate the symptoms 
and preserve oral functional status (30). 
Conclusions
Based on our findings, we can identify the characteris-
tics of metastatic carcinoma in the Korean population. 
In addition, the clinician and oral pathologist can con-
sider the possible presence of metastases, especially in 
patients with known malignant tumors. Of course, our 
estimate of the incidence of oral metastases in the Kore-
an population might not be accurate because the present 
study was a single-center trial, which could cause some 
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bias in favor of certain primary sites and oral sites. How-
ever, it is noteworthy that our research covered a large 
number of patients during the last 32 years, which was 
relatively long period. To establish more definitive cri-
teria for diagnosing of carcinoma metastatic to the oral 
region in the Korean population, well-conducted multi-
center, and large population studies are warranted. 
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